Effects of Lactobacillus plantarum CCFM0236 on hyperglycaemia and insulin resistance in high-fat and streptozotocin-induced type 2 diabetic mice

Journal of Applied Microbiology

Volumn 121, Issue 6, 2016, Pages 1727-1736

  Li, X ^a   Wang, N ^a   Yin, B ^b   Fang, D ^b   Jiang, T ^c   Fang, S ^c   Zhao, J ^a   Zhang, H ^a   Wang, G ^a   Chen, W ^a,d  

^a JIANGNAN UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

^c Welltrust Precision Technology   (China)

^d BEIJING TECHNOLOGY AND BUSINESS UNIVERSITY   (China)

Author keywords

antioxidant; inflammation; leptin; malondialdehyde; streptozotocin; type 2 diabetes mellitus; glucosidase

Indexed keywords

ALDEHYDES; BACILLI; INSULIN; MAMMALS; PATHOLOGY; PEPTIDES;

GLUCOSIDASE; HYPOGLYCAEMIC; INFLAMMATION; INSULIN RESISTANCE; LACTOBACILLUS PLANTARUM; LEPTINS; MALONDIALDEHYDE; STREPTOZOTOCIN; TYPE 2 DIABETES MELLITUS; Α-GLUCOSIDASE;

ANTIOXIDANTS;

ALPHA GLUCOSIDASE; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 10; LEPTIN; MALONALDEHYDE; TUMOR NECROSIS FACTOR; ANTIOXIDANT; GLUCOSE BLOOD LEVEL; PROBIOTIC AGENT;

ANTIOXIDANT; BACTERIUM; BLOOD; DIABETES; DISEASE TREATMENT; ENZYME; ENZYME ACTIVITY; FOOD INTAKE; HORMONE; INHIBITION; INHIBITOR; ORGANIC COMPOUND; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME INHIBITION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LACTOBACILLUS PLANTARUM; LACTOBACILLUS PLANTARUM CCFM0236; LIPID DIET; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BLOOD; C57BL MOUSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; EATING; MALE; METABOLISM;

LACTOBACILLUS PLANTARUM; MUS;

ALPHA-GLUCOSIDASES; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; EATING; INSULIN RESISTANCE; INTERLEUKIN-10; LACTOBACILLUS PLANTARUM; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84995699205     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.13276     Document Type: Article

References (33)

1. Andreasen, A.S., Larsen, N., Pedersen-Skovsgaard, T., Berg, R.M.G., Møller, K., Svendsen, K.D. and Pedersen, B.K. (2010) Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 104, 1831–1838.
2. Ashish Kumar Sharma, B.P.S. (2009) Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats. Eur J Pharm Sci 38, 433–444.
3. Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato, V., Marzotti, S. and Dotta, F. (2005) Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48, 1565–1575.
4. Chen, P., Zhang, Q., Dang, H., Liu, X., Tian, F., Zhao, J. and Chen, W. (2014a) Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin. Nutrition 30, 1061–1068.
5. Chen, P., Zhang, Q., Dang, H., Liu, X., Tian, F., Zhao, J. and Chen, W. (2014b) Oral administration of Lactobacillus rhamnosus CCFM0528 improves glucose tolerance and cytokine secretion in high-fat-fed, streptozotocin-induced type 2 diabetic mice. J Funct Foods 10, 318–326.
6. Chen, P., Zhang, Q., Dang, H., Liu, X., Tian, F., Zhao, J. and Chen, W. (2014c) Screening for potential new probiotic based on probiotic properties and α-glucosidase inhibitory activity. Food Control 35, 65–72.
7. Chen, C.H., Kang, L., Lo, H.C., Hsu, T.H., Lin, F.Y., Lin, Y.S. and Shen, C.L. (2015) Polysaccharides of Trametes versicolor improve bone properties in diabetic rats. J Agric Food Chem 63, 9232–9238.
8. Cui, J., Gu, X., Wang, F., Ouyang, J. and Wang, J. (2015) Purification and structural characterization of an alpha-glucosidase inhibitory polysaccharide from apricot (Armeniaca sibirica L. Lam.) pulp. Carbohydr Polym 121, 309–314.
9. Ejtahed, H.S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M. and Mofid, V. (2012) Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 28, 539–543.
10. Haffner, S.M., Greenberg, A.S., Weston, W.M., Chen, H., Williams, K. and Freed, M.I. (2002) Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106, 679–684.
11. Honda, K., Moto, M., Uchida, N., He, F. and Hashizume, N. (2012) Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice. J Clin Biochem Nutr 51, 96–101.
12. Laakso, M. (1993) How good a marker is insulin level for insulin-resistance. Am J Epidemiol 137, 959–965.
13. Lee, M.J. and Fried, S.K. (2006) Multilevel regulation of leptin storage, turnover, and secretion by feeding and insulin in rat adipose tissue. J Lipid Res 47, 1984–1993.
14. Li, C., Ding, Q., Nie, S.P., Zhang, Y.S., Xiong, T. and Xie, M.Y. (2014) Carrot juice fermented with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats. J Agric Food Chem 62, 11884–11891.
15. Liu, Y., Xu, J., Guo, Y., Xue, Y., Wang, J. and Xue, C. (2015) Ameliorative effect of vanadyl (IV)-ascorbate complex on high-fat high-sucrose diet-induced hyperglycemia, insulin resistance, and oxidative stress in mice. J Trace Elem Med Biol 32, 155–161.
16. Luna, B. and Feinglos, M.N. (2001) Oral agents in the management of type 2 diabetes mellitus. Am Fam Physician 63, 1747–1756.
17. Manaer, T., Yu, L., Zhang, Y., Xiao, X.J. and Nabi, X.H. (2015) Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin. J Ethnopharmacol 169, 269–274.
18. Mu, J., Petrov, A., Eiermann, G.J., Woods, J., Zhou, Y.P., Li, Z. and Zhang, B.B. (2009) Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes. Eur J Pharmacol 623, 148–154.
19. Murotomi, K., Umeno, A., Yasunaga, M., Shichiri, M., Ishida, N., Koike, T. and Nakajima, Y. (2015) Oleuropein-rich diet attenuates hyperglycemia and impaired glucose tolerance in type 2 diabetes model mouse. J Agric Food Chem 63, 6715–6722.
20. Naito, E., Yoshida, Y., Makino, K., Kounoshi, Y., Kunihiro, S., Takahashi, R. and Ishikawa, F. (2011) Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 110, 650–657.
21. Phung, O.J., Baker, W.L., Tongbram, V., Bhardwaj, A. and Coleman, C.I. (2012) Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis. Ann Pharmacother 46, 469–476.
22. Ramchandran, L. and Shah, N.P. (2008) Proteolytic profiles and angiotensin-I converting enzyme and alpha-glucosidase inhibitory activities of selected lactic acid bacteria. J Food Sci 73, M75–M81.
23. Ramchandran, L. and Shah, N.P. (2009) Effect of exopolysaccharides and inulin on the proteolytic, angiotensin-I-converting enzyme- andα-glucosidase-inhibitory activities as well as on textural and rheological properties of low-fat yogurt during refrigerated storage. Dairy Sci Technol 89, 583–600.
24. Ramchandran, L. and Shah, N.P. (2010) Influence of addition of Raftiline HP (R) on the growth, proteolytic, ACE- and alpha-glucosidase inhibitory activities of selected lactic acid bacteria and Bifidobacterium. LWT-Food Sci Technol 43, 146–152.
25. Salas-Salvado, J., Martinez-Gonzalez, M.A., Bullo, M. and Ros, E. (2011) The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis 21(Suppl 2), B32–B48.
26. Shaw, J.E., Sicree, R.A. and Zimmet, P.Z. (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87, 4–14.
27. Skovso, S. (2014) Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Invest 5, 349–358.
28. Stumvoll, M., Mitrakou, A., Pimenta, W., Jenssen, T., Yki-Jarvinen, H., Van Haeften, T. and Gerich, J. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23, 295–301.
29. Tabuchi, M., Ozaki, M., Tamura, A., Yamada, N., Ishida, T., Hosoda, M. and Hosono, A. (2003) Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67, 1421–1424.
30. Tahrani, A.A., Piya, M.K., Kennedy, A. and Barnett, A.H. (2010) Glycaemic control in type 2 diabetes: targets and new therapies. Pharmacol Ther 125, 328–361.
31. Yadav, H., Jain, S. and Sinha, P.R. (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23, 62–68.
32. Yun, S.I., Park, H.O. and Kang, J.H. (2009) Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 107, 1681–1686.
33. Zhang, Y., Wang, L.F., Zhang, J.C., Li, Y.X., He, Q.W., Li, H. and Zhang, H.P. (2014) Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. Eur J Nutr 53, 221–232.